Abiopharma

FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation

Pacific Health Care Organization, Inc. Reports its Third Quarter 2025 Financial Results

Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025

Travere Therapeutics to Participate at Upcoming Investor Conferences

Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026

Precipio Announces Q3-2025 Shareholder Update Call

CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH

Cardinal Health Board of Directors Approves Quarterly Dividend

Guardant Health Announces Proposed Public Offering of Common Stock

Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033